Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
Description
BACKGROUND: COVID-19 vaccines that offer broad-spectrum protection are needed. We aimed to evaluate the safety and immunogenicity of multivalent vaccines, SCTV01E and SCTV01C, and compare them with an inactivated vaccine.
